I-PREDICT: Innovative Physiology-based pharmacokinetic model to pREdict Drug exposure In neonates undergoing Cooling Therapy
Investigation of bidirectional pharmacokinetic drug-drug interaction between vicagrel, a novel analogue for the antiplatelet drug clopidogrel, and atorvastatin
I-PREDICT: Innovative Physiology-based pharmacokinetic model to pREdict Drug exposure In neonates undergoing Cooling Therapy.
Personalized pharmacotherapy in neonates: from (patho)physiology to innovative pharmacokinetic and pharmacodynamic tools
Pharmacokinetics during therapeutic hypothermia in neonates: from pathophysiology to translational knowledge and physiologically-based pharmacokinetic (PBPK) modeling
Generic Workflow to Predict Medicine Concentrations in Human Milk Using Physiologically-Based Pharmacokinetic (PBPK) Modelling—A Contribution from the ConcePTION Project
PREDICTION FETAL EXPOSURE TO ACETAMINOPHEN AND ITS METABOLITES USING PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING.
PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING TO CHARACTERIZE ACETAMINOPHEN TARGET ATTAINMENT AND HEPATOTOXICITY IN NON-PREGNANT AND PREGNANT WOMEN.
PREDICTION FETAL EXPOSURE TO ACETAMINOPHEN AND ITS METABOLITES USING PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING.